tranexamic acid has been researched along with Leukemia, Myeloid in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to determine the efficacy of the antifibrinolytic agent tranexamic acid (TA) in reducing bleeding and platelet transfusions during the treatment of acute myeloid leukemia (AML), we conducted a randomized placebo-controlled double-blind study." | 9.08 | A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. ( Ben-Bassat, I; Blumenthal, R; Chetrit, A; Eldor, A; Katz, Y; Ramot, B; Shpilberg, O; Sofer, O, 1995) |
| "In order to determine the efficacy of the antifibrinolytic agent tranexamic acid (TA) in reducing bleeding and platelet transfusions during the treatment of acute myeloid leukemia (AML), we conducted a randomized placebo-controlled double-blind study." | 5.08 | A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. ( Ben-Bassat, I; Blumenthal, R; Chetrit, A; Eldor, A; Katz, Y; Ramot, B; Shpilberg, O; Sofer, O, 1995) |
| "Gingival hemorrhage is recognized as a symptom of MDS, a rare group of potentially fatal hematological disorders, but it has not previously been documented as a presenting sign." | 2.40 | Gingival hemorrhage, myelodysplastic syndromes, and acute myeloid leukemia. A case report. ( Chapple, IL; Murray, JA; Saxby, MS, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shpilberg, O | 1 |
| Blumenthal, R | 1 |
| Sofer, O | 1 |
| Katz, Y | 1 |
| Chetrit, A | 1 |
| Ramot, B | 2 |
| Eldor, A | 1 |
| Ben-Bassat, I | 2 |
| Chapple, IL | 1 |
| Saxby, MS | 1 |
| Murray, JA | 1 |
| Boutonnat, J | 1 |
| Barbier, M | 1 |
| Muirhead, K | 1 |
| Mousseau, M | 1 |
| Grunwald, D | 1 |
| Ronot, X | 1 |
| Seigneurin, D | 1 |
| Sakuragawa, N | 1 |
| Takahashi, K | 1 |
| Hoshiyama, M | 1 |
| Jimbo, C | 1 |
| Matsuoka, M | 1 |
| Douer, D | 1 |
1 review available for tranexamic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
Gingival hemorrhage, myelodysplastic syndromes, and acute myeloid leukemia. A case report.
Topics: Acute Disease; Biopsy, Needle; Bone Marrow Cells; Chronic Disease; Diagnosis, Differential; Gingival | 1999 |
1 trial available for tranexamic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Female; Hemorr | 1995 |
3 other studies available for tranexamic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: simultaneous assessment of proliferation, apoptosis, and necrosis.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member | 2000 |
Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
Topics: Acute Disease; Animals; Aprotinin; Blood Coagulation; Chromatography, Gel; Disseminated Intravascula | 1976 |
Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions.
Topics: Acute Disease; Adult; Blood Transfusion; Erythrocyte Transfusion; Female; Humans; Leukemia, Myeloid; | 1990 |